Macromoltek
Computational antibody design
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs. Macromoltek is a Y Combinator company (Winter 2018). YC-listed status: Active.
- Website
- macromoltek.com
- Location
- Austin, TX, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Macromoltek — AI-driven computational platform for antibody discovery, design, and optimization for biotech and pharma partners. · Service · Project
Links
- Y Combinator profileycombinator